Literature DB >> 10961625

Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy.

D G Fujikawa1, H H Itabashi, A Wu, S S Shinmei.   

Abstract

PURPOSE: To determine the regional distribution of neuronal damage caused strictly by status epilepticus (SE) without systemic complications, underlying brain pathology, or a history of preexisting epilepsy.
METHODS: The medical records and electroencephalograms (EEGs) of three deceased patients who developed SE in the hospital were reviewed. Their brains were formalin-fixed, and 17 brain regions were selected, embedded in paraffin, and sectioned. Alternate sections were stained with either hematoxylin and eosin and cresyl violet to determine the extent of neuronal loss and gliosis or glial fibrillary astrocytic protein to confirm the extent of astrocytic proliferation.
RESULTS: The three patients died 11 to 27 days after the onset of focal motor SE; none had hypotension, hypoxemia, hypoglycemia, or significant hyperthermia. Two patients had no prior seizures and no underlying brain pathology. The third patient, who had leptomeningeal carcinomatosis, had one seizure 2 months before the onset of SE. The duration of SE was 8.8 hours to 3 days. EEGs showed unilateral temporal lobe sharp-wave discharges in one patient and independent temporal lobe sharp-wave discharges bilaterally in the other two patients. In addition to widespread neuronal loss and reactive gliosis in the hippocampus, amygdala, dorsomedial thalamic nucleus, and Purkinje cell layer of the cerebellum, we report for the first time periamygdaloid (piriform) and entorhinal cortical damage occurring acutely after SE in humans.
CONCLUSIONS: In the absence of systemic complications or preexisting epilepsy, SE produces neuronal loss in a distribution similar to that from domoic acid-induced SE in humans and from kainic acid- and pilocarpine-induced SE in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961625     DOI: 10.1111/j.1528-1157.2000.tb00283.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  46 in total

1.  Hippocampal shape analysis in status epilepticus associated with acute encephalitis.

Authors:  Kitti Kaiboriboon; R Edward Hogan
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

Review 2.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

3.  Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Lynda T Wells; Christopher L Wallace; Michael A Dawes; Lei Liu; Xin-Qun Wang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-09-15       Impact factor: 5.067

4.  Localisation-related nonconvulsive status epilepticus: Further evidence of permanent cerebral damage.

Authors:  José L Fernández-Torre; Javier Figols; Marián Martínez-Martínez; Jesús González-Rato; Jesús Calleja
Journal:  J Neurol       Date:  2005-09-02       Impact factor: 4.849

Review 5.  Is epilepsy a preventable disorder? New evidence from animal models.

Authors:  Kathryn A Giblin; Hal Blumenfeld
Journal:  Neuroscientist       Date:  2010-06       Impact factor: 7.519

6.  A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.

Authors:  W Pouliot; S L Bealer; B Roach; F E Dudek
Journal:  Neurotoxicology       Date:  2016-08-12       Impact factor: 4.294

7.  Increased oxidant status in children with breath-holding spells.

Authors:  Mustafa Calik; Mahmut Abuhandan; Ali Aycicek; Abdullah Taskin; Sahabettin Selek; Akin Iscan
Journal:  Childs Nerv Syst       Date:  2012-12-19       Impact factor: 1.475

Review 8.  Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features.

Authors:  Maria Thom; Sofia Eriksson; Lillian Martinian; Luis O Caboclo; Andrew W McEvoy; John S Duncan; Sanjay M Sisodiya
Journal:  J Neuropathol Exp Neurol       Date:  2009-08       Impact factor: 3.685

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

10.  Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry.

Authors:  Laxmikant S Deshpande; Jeffrey K Lou; Ali Mian; Robert E Blair; Sompong Sombati; Elisa Attkisson; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.